Loading organizations...
Biotech company specializing in allergy and inflammatory disease treatments
Allegria Therapeutics has raised $8.6M across 2 funding rounds.
Allegria Therapeutics has raised $8.6M in total across 2 funding rounds.
Allegria Therapeutics has raised $8.6M in total across 2 funding rounds.
Allegria Therapeutics's investors include Peter Sejer Andersen, Forty51 Ventures, Lichtsteiner Foundation.
Allegria Therapeutics has raised $8.6M across 2 funding rounds. Most recently, it raised $5.1M Seed Extension in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 11, 2025 | $5.1M Seed Extension | Peter Sejer Andersen | Forty51 Ventures, Lichtsteiner Foundation |
| May 6, 2024 | $3.5M Seed | Forty51 Ventures |